Similar to previous reports, we detected virus-specific T cell responses in acute and convalescent COVID-19 patients targeting SARS-CoV-2 structural proteins, including spike, nucleocapsid, and membrane40–45. The gene discussed is CHMP5; the disease is COVID-19.